Toward a Framework to Improve Diversity and Inclusion in Clinical Trials: Proceedings of a Workshop

Optimizing Public–Private Partnerships for Clinical Cancer Research: Proceedings of a Workshop

Adult Attention-Deficit/Hyperactivity Disorder: Diagnosis, Treatment, and Implications for Drug Development: Proceedings of a Workshop

Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics: Proceedings of a Workshop

Preparing the Future Workforce in Drug Research and Development: Proceedings of a Workshop

Defining and Evaluating In-Home Drug Disposal Systems For Opioid Analgesics: Proceedings of a Workshop

Applying Lessons Learned from COVID-19 Research and Development to Future Epidemics: Proceedings of a Workshop

Accelerating the Development and Uptake of Rapid Diagnostics to Address Antibiotic Resistance: Proceedings of a Workshop

Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop

Envisioning a Transformed Clinical Trials Enterprise for 2030: Proceedings of a Workshop

Drug Research and Development for Adults Across the Older Age Span: Proceedings of a Workshop

Innovation in Drug Research and Development for Prevalent Chronic Diseases: Proceedings of a Workshop

Improving the Evidence Base for Treatment Decision Making for Older Adults with Cancer: Proceedings of a Workshop—in Brief

The Role of Digital Health Technologies in Drug Development: Proceedings of a Workshop

Reflections on Sharing Clinical Trial Data: Challenges and a Way Forward: Proceedings of a Workshop

Enhancing Scientific Reproducibility in Biomedical Research Through Transparent Reporting: Proceedings of a Workshop

Virtual Clinical Trials: Challenges and Opportunities: Proceedings of a Workshop

Examining the Impact of Real-World Evidence on Medical Product Development: Proceedings of a Workshop Series

Advancing the Science of Patient Input in Medical Product R&D: Towards a Research Agenda: Proceedings of a Workshop—in Brief

Examining the Impact of Real-World Evidence on Medical Product Development: II. Practical Approaches: Proceedings of a Workshop—in Brief

The Drug Development Paradigm in Oncology: Proceedings of a Workshop

Examining the Impact of Real-World Evidence on Medical Product Development: I. Incentives: Proceedings of a Workshop—in Brief

Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development: Proceedings of a Workshop

Real-World Evidence Generation and Evaluation of Therapeutics: Proceedings of a Workshop

Deriving Drug Discovery Value from Large-Scale Genetic Bioresources: Proceedings of a Workshop

Advancing the Discipline of Regulatory Science for Medical Product Development: An Update on Progress and a Forward-Looking Agenda: Workshop Summary

Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary

Characterizing Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop in Brief

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary

The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS: Challenges and Opportunities: Summary of a Joint Workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences

Large Simple Trials and Knowledge Generation in a Learning Health System: Workshop Summary

International Regulatory Harmonization Amid Globalization of Drug Development: Workshop Summary

Sharing Clinical Research Data: Workshop Summary

Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis: Workshop Summary

Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary

Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary

Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary

Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary

Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary

The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science

The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa: Global and Local Challenges and Solutions: Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa

Building a National Framework for the Establishment of Regulatory Science for Drug Development: Workshop Summary

Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary

The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary

Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary

Accelerating the Development of Biomarkers for Drug Safety: Workshop Summary

Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary

Addressing the Barriers to Pediatric Drug Development: Workshop Summary

Emerging Safety Science: Workshop Summary

Challenges for the FDA: The Future of Drug Safety: Workshop Summary

Understanding the Benefits and Risks of Pharmaceuticals: Workshop Summary

Adverse Drug Event Reporting: The Roles of Consumers and Health-Care Professionals: Workshop Summary